ArticleMaterials today. Bio2026

Daidzein-engineered high-accumulation self-therapeutic nanoplatform drives androgen receptor degradation via ubiquitination-proteasome system to overcome enzalutamide resistance in castration-resistant prostate cancer.

Zhaoxiang Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.